Silke Schelenz

4.7k total citations · 2 hit papers
75 papers, 2.9k citations indexed

About

Silke Schelenz is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Silke Schelenz has authored 75 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Infectious Diseases, 43 papers in Epidemiology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Silke Schelenz's work include Antifungal resistance and susceptibility (44 papers), Fungal Infections and Studies (26 papers) and Cystic Fibrosis Research Advances (9 papers). Silke Schelenz is often cited by papers focused on Antifungal resistance and susceptibility (44 papers), Fungal Infections and Studies (26 papers) and Cystic Fibrosis Research Advances (9 papers). Silke Schelenz collaborates with scholars based in United Kingdom, United States and Netherlands. Silke Schelenz's co-authors include Darius Armstrong‐James, Alireza Abdolrasouli, Elizabeth M. Johnson, Colin Brown, Andrew M. Borman, Jacques F. Meis, Anuradha Chowdhary, Matthew C. Fisher, Johanna Rhodes and Rohini Manuel and has published in prestigious journals such as Clinical Microbiology Reviews, Kidney International and Journal of Clinical Microbiology.

In The Last Decade

Silke Schelenz

66 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First hospital outbreak of the globally emerging Candida auris in a European hospital

2016 565 citations Silke Schelenz, Ferry Hagen et al. profile →
Candida auris: a Review of the Literature

2017 422 citations Silke Schelenz et al. profile →

Peers

Countries citing papers authored by Silke Schelenz

Since Specialization

Citations

This map shows the geographic impact of Silke Schelenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Schelenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Schelenz more than expected).

Fields of papers citing papers by Silke Schelenz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Schelenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Schelenz. The network helps show where Silke Schelenz may publish in the future.

Co-authorship network of co-authors of Silke Schelenz

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Schelenz. A scholar is included among the top collaborators of Silke Schelenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Schelenz. Silke Schelenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antifungal stewardship in the UK: where are we now? 2024 ·JAC-Antimicrobial Resistance ·Silke Schelenz, Samir Agrawal, A. J. Brady, (unknown), (unknown), Edward L. Howes, Tim Felton, Christianne Micallef, (unknown), Tihana Bicanic, P. Lewis White	0
2	[⁶⁸Ga]Ga-Schizokinen, a Potential Radiotracer for Selective Bacterial Infection Imaging 2024 ·ACS Infectious Diseases ·(unknown), (unknown), (unknown), Margaret S. Cooper, (unknown), Agostino Cilibrizzi, Philip J. Blower, Robert C. Hider, Oliver Lyons, Silke Schelenz, Varun Mehra, Vincenzo Abbate	2
3	A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship 2022 ·JAC-Antimicrobial Resistance ·Clare Logan, Carolyn Hemsley, A Fife, Jonathan D. Edgeworth, Andrea Mazzella, P. Wade, Anna L. Goodman, Philip Hopkins, Duncan Wyncoll, Jonathan Ball, Tim Planche, Silke Schelenz, Tihana Bicanic	3
4	Bronchiectasis severity correlates with outcome in patients with primary antibody deficiency 2021 ·Thorax ·Jimstan Periselneris, Silke Schelenz, Michael R. Loebinger, Patricia Macedo, Zoe Adhya, Darius Armstrong‐James, William P. Kelleher	3
5	Comparative Evaluation of MIRONAUT-AM and CLSI broth microdilution method for antifungal susceptibility testing of Aspergillus species against four commonly used antifungals 2020 ·Medical Mycology ·(unknown), Newara Ramadan, Silke Schelenz, Darius Armstrong‐James	6
6	Correction: Care for critically ill patients with COVID-19: don’t forget the eyes 2020 ·Eye ·(unknown), Edward Pringle, Neda Minakaran, Silke Schelenz	1
7	The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis 2020 ·Journal of Cystic Fibrosis ·Leah Cuthbertson, (unknown), Phillip James, Michael J. Cox, Diana Bilton, Silke Schelenz, Michael R. Loebinger, William Cookson, Nicholas J. Simmonds, Miriam F. Moffatt	42
8	Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting 2019 ·International Journal of Antimicrobial Agents ·Nikki Kenters, Martin Kiernan, Anuradha Chowdhary, David W. Denning, Javier Pemán, (unknown), Silke Schelenz, Ermira Tartari, Andreas F. Widmer, Jacques F. Meis, Andreas Voß	78
9	Rapid and extensive karyotype diversification in haploid clinical Candida auris isolates 2019 ·Current Genetics ·Gustavo Bravo Ruiz, (unknown), (unknown), Silke Schelenz, Neil A. R. Gow, Alexander Lorenz	45
10	Airway persistence by the emerging multi‐azole‐resistant Rasamsonia argillacea complex in cystic fibrosis 2018 ·Mycoses ·Alireza Abdolrasouli, (unknown), Johanna Rhodes, Ferry Hagen, Jochem B. Buil, (unknown), (unknown), Anand Shah, (unknown), J.S. Elborn, Andrew Jones, Jacques F. Meis, Matthew C. Fisher, Silke Schelenz, Nicholas J. Simmonds, Darius Armstrong‐James	14
11	High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre 2018 ·International Journal of Antimicrobial Agents ·Alireza Abdolrasouli, Andrew Scourfield, Johanna Rhodes, Anand Shah, J.S. Elborn, Matthew C. Fisher, Silke Schelenz, Darius Armstrong‐James	37
12	A Sweet Response to a Sour Situation: The Role of Soluble Pattern Recognition Receptors in the Innate Immune Response to Invasive Aspergillus fumigatus Infections 2016 ·PLoS Pathogens ·Stefan Bidula, Silke Schelenz	9
13	The Serum Opsonin L-ficolin Is Detected in Lungs of Human Transplant Recipients Following Fungal Infections and Modulates Inflammation and Killing ofAspergillus fumigatus 2015 ·The Journal of Infectious Diseases ·Stefan Bidula, Darren W. Sexton, Alireza Abdolrasouli, Anand Shah, Anna Reed, Darius Armstrong‐James, Silke Schelenz	41
14	British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases 2015 ·The Lancet Infectious Diseases ·Silke Schelenz, Rosemary A. Barnes, Richard C. Barton, Joanne Cleverley, Sebastian Lucas, Christopher C. Kibbler, David W. Denning	130
15	Serum opsonin ficolin-A enhances host–fungal interactions and modulates cytokine expression from human monocyte-derived macrophages and neutrophils following Aspergillus fumigatus challenge 2015 ·Medical Microbiology and Immunology ·Stefan Bidula, Darren W. Sexton, Silke Schelenz	17
16	Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre 2011 ·Annals of Oncology ·Silke Schelenz, (unknown), (unknown)	39
17	Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors 2010 ·Journal of Oral Pathology and Medicine ·Silke Schelenz, (unknown), (unknown), (unknown), (unknown), Peter Baker, Paul Hunter	74
18	Internet treatment of sexually transmitted infections – a public health hazard? 2007 ·BMC Public Health ·Roberto Vivancos, Silke Schelenz, Yoon K. Loke	13
19	Infective endocarditis in dialysis patients: New challenges and old 2003 ·Kidney International ·Timothy Doulton, (unknown), Hugh Cairns, Silke Schelenz, Susannah Eykyn, Patrick O’Donnell, John B. Chambers, (unknown), David Goldsmith	76
20	Candidaemia in a London teaching hospital: analysis of 128 cases over a 7‐year period 2003 ·Mycoses ·Silke Schelenz, W. R. Gransden	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact